We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+9.1%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$403M
AUM Growth
+$250M
Cap. Flow
+$235M
Cap. Flow %
58.3%
Top 10 Hldgs %
6.29%
Holding
793
New
457
Increased
87
Reduced
29
Closed
219

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$2.8M
2
TGT icon
Target
TGT
+$2.73M
3
LMT icon
Lockheed Martin
LMT
+$2.7M
4
DLTR icon
Dollar Tree
DLTR
+$2.53M
5
NOC icon
Northrop Grumman
NOC
+$2.29M

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$2.59M
2
AAPL icon
Apple
AAPL
+$2.41M
3
CAG icon
Conagra Brands
CAG
+$1.87M
4
RHT
Red Hat Inc
RHT
+$1.67M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.45M

Sector Composition

Rank Sector Weight
1 Technology 21.61%
2 Consumer Discretionary 19.21%
3 Industrials 13.4%
4 Healthcare 12.85%
5 Financials 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDLZ icon
226
Mondelez International
MDLZ
$79.7B
$692K 0.17%
+15,600
New +$672K
WP
227
DELISTED
Worldpay, Inc.
WP
$685K 0.17%
+11,486
New +$664K
LPNT
228
DELISTED
LifePoint Health, Inc.
LPNT
$685K 0.17%
+12,063
New +$698K
CAR icon
229
Avis
CAR
$4.93B
$682K 0.17%
+18,599
New +$674K
VRTX icon
230
Vertex Pharmaceuticals
VRTX
$139B
$682K 0.17%
+9,253
New +$753K
FRAN
231
DELISTED
Francesca's Holdings Corporation
FRAN
$680K 0.17%
3,142
+1,050
+50% +$218K
CC icon
232
Chemours
CC
$2.39B
$678K 0.17%
+30,700
New +$630K
CRTO icon
233
Criteo S.A.
CRTO
$845M
$674K 0.17%
+16,400
New +$639K
NBIS
234
Nebius Group N.V.
NBIS
$59.4B
$671K 0.17%
+33,318
New +$655K
DBI icon
235
Designer Brands
DBI
$278M
$669K 0.17%
+29,520
New +$670K
VTLE
236
DELISTED
Vital Energy
VTLE
$667K 0.17%
+2,360
New +$649K
PHG icon
237
Philips
PHG
$26.3B
$666K 0.17%
+29,423
New +$642K
MMS icon
238
Maximus
MMS
$3.12B
$654K 0.16%
+11,718
New +$637K
MSCC
239
DELISTED
Microsemi Corp
MSCC
$654K 0.16%
12,117
+6,617
+120% +$323K
MET icon
240
MetLife
MET
$61.2B
$653K 0.16%
+13,599
New +$624K
CIM
241
Chimera Investment
CIM
$964M
$652K 0.16%
+12,767
New +$625K
SYNH
242
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$652K 0.16%
+12,400
New +$600K
LOPE icon
243
Grand Canyon Education
LOPE
$3.91B
$651K 0.16%
+11,143
New +$570K
BIO icon
244
Bio-Rad Laboratories Class A
BIO
$10.4B
$649K 0.16%
+3,563
New +$607K
ENS icon
245
EnerSys
ENS
$6.89B
$647K 0.16%
+8,284
New +$607K
SHOO icon
246
Steven Madden
SHOO
$3.27B
$647K 0.16%
+27,150
New +$660K
SC
247
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$642K 0.16%
+47,588
New +$628K
TAL icon
248
TAL Education Group
TAL
$6.5B
$638K 0.16%
+54,600
New +$667K
TIVO
249
DELISTED
Tivo Inc
TIVO
$633K 0.16%
+30,300
New +$616K
RJF icon
250
Raymond James Financial
RJF
$33.9B
$632K 0.16%
+13,685
New +$605K

Similar funds

Bayesian Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Bayesian Capital Management held 793 positions worth $403M, up 164% from $152M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.

Bayesian Capital Management deployed $235M of net new capital in Q4 2016, opening 457 new positions and adding to 87 existing holdings. Its largest new stake was Procter & Gamble: 32,800 shares worth $2.76M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Zebra Technologies, an estimated $419K trimmed.

  • Bayesian Capital Management's largest Q4 2016 buy was Procter & Gamble: 32,800 shares worth $2.76M.
  • Bayesian Capital Management added most to Ross Stores in Q4 2016, an estimated $1.85M increase.
  • Bayesian Capital Management's biggest Q4 2016 reduction was Zebra Technologies, cutting an estimated $419K.
  • Bayesian Capital Management fully exited Adobe in Q4 2016, selling an estimated $2.59M.
  • Bayesian Capital Management's ten largest holdings make up 6.3% of its $403M portfolio in Q4 2016.
  • Bayesian Capital Management opened 457 new positions and closed 219 in Q4 2016.
  • Bayesian Capital Management's portfolio value rose 164% quarter-over-quarter to $403M.

Based on Bayesian Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.